Mini-Stem System® received its CE Mark approval in 2024 Dr. Neophytos Demetriades, Dr. Marco Spoliti, and Dr. Francesco Calvani ...

GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.

GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...

GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...

GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has appointed Dr.

GSK on Monday also said it has start the GBP2 billion buyback programme that it announced earlier this month, starting with an initial GBP700 million tranche.

Chen, D. and Li, L. (2025) Huge Pelvic GIST Got Good Control after Resistance to Tyrosine Kinase Inhibitors by SIB-IMRT: A ...

Chair Jane Bell welcomed Dr. George to the Board and said, “Greg brings not only a high conviction in Mesoblast and our therapies but additionally important operational and strategic dimensions to our ...

The European Society for Medical Oncology (ESMO) guidelines recommend life-long systemic tyrosine kinase inhibitor (TKI) ...

Learn about Pseudoangiomatous Stromal Hyperplasia (PASH) of the breast, its diagnosis, hormonal influences, and holistic ...